NCT01225237View on ClinicalTrials.gov

A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Ramosetron

oral

DRUG

Placebo

oral

Trial Locations (4)

Unknown

Hokkaido

Kansai

Kantou

Kyusyu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY